Press release
PREMIER Biosoft International releases AlleleID version 7.01 offering enhanced support for custom MLPA® probe design
Palo Alto, California – March 5, 2009 PREMIER Biosoft International today announced the world wide release of AlleleID version 7.01. AlleleID, the suite for qPCR and microarrays, now includes support for the latest design guidelines laid down by MRC-Holland, the inventors of the technology. MLPA® is an easy-to-use molecular biology technique which has been gaining attention especially for studies of DNA copy number changes.With this release, AlleleID now also supports the UCSC genome browser file format, developed and maintained by the Genome Bioinformatics Group, University of California at Santa Cruz. AlleleID 7.01 includes a greatly enhanced automatic homology avoidance algorithm that enables users to design assays with greater specificity, avoiding unrelated SNPs at the same time.
For details, please visit: http://www.premierbiosoft.com/bacterial-identification/realtime-PCR/mlpa.html
About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.
About MRC-Holland
MRC-Holland published its first article about MLPA® technology in 2002 and since then, its product range has grown explosively. The company now offers well over a 200 different MLPA® tests for a wide range of applications, from rare genetic diseases to tumor analysis. MRC-Holland aims to make the MLPA® technology available to all scientists and works in close collaboration with researchers around the world. More information about MRC-Holland can be found on www.MLPA.com.
Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com
PREMIER Biosoft is a leading software solutions company and author exclusively for molecular biologists. Our software have been used and appreciated by researchers worldwide and have been often cited as well.
PREMIER Biosoft International
3786 Corina Way
Palo Alto, CA 94303-4504
Fax: 650-618-1773
Phone: 888-847-7494
Email: support@premierbiosoft.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PREMIER Biosoft International releases AlleleID version 7.01 offering enhanced support for custom MLPA® probe design here
News-ID: 70860 • Views: …
More Releases for MLPA
Nephro Genetic Testing Market Outlook 2022- Explains COVID-19 Impact, Share and …
Global Nephro Genetic Testing Market Report provides Market Size, Trends, forecast period with analysis of the market's historic and forecast growth, drivers and restraints affecting the market, and highlights of the opportunities that companies in the industry can take on. The Nephro Genetic Testing research report examines the approach line of business. Also, the research survey studies market activities like drivers, new possibilities, insight, obstacles.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5609636
Top…
Commensuration With Innovative Pace To Take The Cardiovascular Genomic Diagnosti …
The global Cardiovascular Genomic Diagnostics Market is on the verge of witnessing a drastic In Upcoming Years. The digital renaissance is dictating the terms for the industry. AI-powered data core is being used for delivering insights. Also, the virtual workforce is being developed with a transfer of digital skills, that too, from a plethora of innovative ecosystems and industries. Conversational AI is being deployed for helping the end-users with timely…
Global Hematology Probes Market Trends, Size, Competitive Analysis and Forecast …
The global hematology probes market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The growing research related to the genome coupled with the advancements in the biotechnology vertical has paved numerous opportunities for market growth. Some other major factors which primarily include the rising prevalence of blood disorders along with the rising awareness about such disorders and the presence of sophisticated & advanced technologies are…
Global Chromosome Enumeration Probes (CEP) Market Top Leading Players with Strat …
The global chromosome enumeration probes (CEP) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The continuous growing prevalence of target disorders, the rising investments in in-vitro diagnostics space, coupled with the technological advancements in in-situ hybridization (ISH) are a few of the pivotal factors driving the market growth. Another key factor driving the market growth includes the key role of CEPs in many applications,…
What's Happening With Cardiovascular genomic diagnostics market? Color Genomics, …
Heart related disorders are mostly inherited from parents to their children. Cardiovascular genomic di-agnostics testing helps in detecting these inherited diseases such as cardiac channelopathies and con-genital heart diseases. Besides cardiovascular genomic diagnostics can also be helpful for family members who have risks of developing heart problems. These genetic disorders affect by impairing development of blood vessels which leads to onset of heart diseases. Therefore, cardiovascular genomic diagnostics help in…
PREMIER Biosoft and PamGene International B.V. form an alliance
Palo Alto, California—February 15th 2007. PREMIER Biosoft International, a leading bioinformatics company, and PamGene International B.V., owner of patented technologies for second-generation microarray products, have come together to develop a software tool to design custom oligos for use in MLPA® based assays.
Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method for assessing tens to hundreds of gene copy number changes, single-nucleotide polymorphisms (SNPs), insertions and deletions and methylation markers in genomic…
